We help organisations – who may be at any stage of developing a new diagnostic technology – by providing robust performance testing.
This provides evidence to support the independent diagnostic test evaluation necessary to move new innovative technologies to the next stage of their development or to launch for mainstream use.
Based in the Biosphere, Newcastle Helix life sciences quarter, the lab team works with UK and international clients around the globe to accelerate the advancement and use of the most innovative diagnostics.
Our diagnostic evaluation and validation services provide evidence to support the independent evaluation and validation necessary to move new technologies to the next stage of their development or to launch to market for mainstream use.
The lab houses cutting-edge technology and a large biobank of well-characterised clinical Covid and other biological samples.
Offering a range of specialist expertise, our team includes molecular biologists, life scientists, methodologists and clinical research nurses .
We are proud to have already supported the development of 20 Covid-19 diagnostic devices to help tackle pandemic and are now working on a wider range of innovations to provide greater resilience for fighting future virus and health threats including other infectious diseases and cancers.